Search for David Graham and
  1. October 11, 2013

    How developers can benefit from early partnerships with artists

    There is nothing new under the sun, as Shakespeare reminds us, quoting Ecclesiastes and thereby proving the point. Everyone...

  2. March 28, 2013

    Western funds seek a passage to India

    Western fund houses with a presence in India are failing to persuade locals there to buy equity funds – an unfortunate...

  1. March 15, 2013

    Climate change threatens Neolithic art

    Climate change could have a devastating effect on Neolithic and Bronze Age rock art in Northumberland, experts warn. The...

  2. September 5, 2011

    Oman pushes on with maritime revival

    Oman is seeking to take a recent maritime revival to a new level and at the same time is set to be the first Arab nation to...

  3. June 11, 2010

    New health study deals further blow to GSK's Avandia

    GlaxoSmithKline's blockbuster diabetes treatment Avandia may have caused unnecessary strokes, heart attacks and deaths in...

  4. June 10, 2010

    Health study deals further blow to GSK’s Avandia

    GlaxoSmithKline’s blockbuster diabetes treatment Avandia may have caused unnecessary strokes, heart attacks and deaths in...

  5. September 8, 2009

    Tea prices heading for a correction

    From Mr David Graham. Sir, As a family with five generations of experience in tea, a tea factory in Rwanda, a trading house...

  6. June 6, 2008

    Stars of India and Pakistan glow brightly in troubled Asian skies

    India has long been regarded as a promised land for managers of emerging markets funds. And these days, many are increasing...

  7. July 31, 2007

    Backing for GSK diabetes drug

    GlaxoSmithKline’s diabetes drug Avandia should be allowed to remain on the market in spite of concerns it may raise...

  8. July 30, 2007

    Movers and Shakers

    Katy Pi Chin Tang has joined the Hong Kong office of Julius Baer as managing director and senior advisor. She has been a...

  9. August 12, 2005

    FDA clamps down on Roche acne drug

    US regulators on Friday tightened the distribution and prescription of Accutane to prevent the use of the acne treatment by...

  10. April 29, 2005

    Crestor sales top $1bn for AZ

    AstraZeneca's controversial cholesterol-lowering drug Crestor has become a "blockbuster" with annual sales topping $1bn...

  11. April 28, 2005

    Astra banks on its ‘blockbuster’ drug

    AstraZeneca’s controversial cholesterol-lowering drug Crestor has become a “blockbuster” with annual sales topping $1bn,...

  12. March 21, 2005

    Drug agency's efficacy in doubt

    After months spent reviewing the safety of a class of painkiller, the efficacy of the US Food and Drug Administration is...

  13. March 4, 2005

    Five get a fix

    Another of the Famous Five has had a narrow squeak. In November, David Graham, a scientist at the US Food and Drug...

  14. March 3, 2005

    Lex: AstraZeneca

    Another of the famous five has had a narrow escape. In November, David Graham, a scientist at the US Food and Drug...

  15. March 3, 2005

    FDA eases fears over AstraZeneca drug

    AstraZeneca shares rose on Thursday morning after US regulators said that Crestor, the group?s cholesterol drug, did not...

  16. February 18, 2005

    Watchdog imposes curbs on dosages of Cox-2 pain drugs

    European regulators yesterday recommended curbs on the class of painkillers known as Cox-2 inhibitors but stopped short of...

  17. February 18, 2005

    Regulators recommend curbs on Cox-2s

    European regulators yesterday recommended curbs on a widely used class of painkillers known as Cox-2 inhibitors but stopped...

  18. February 18, 2005

    European medicines watchdog imposes dosage limits on Cox-2 pain relievers

    European regulators yesterday recommended curbs on the class of painkillers known as Cox-2 inhibitors but stopped short of...

  19. February 17, 2005

    Expert tells of risks from all Cox-2 drugs

    Increased risk of heart attacks and strokes applies to the entire class of pain drugs known as Cox-2 inhibitors, a US...

  20. February 16, 2005

    Regulating drugs

    Pharmaceuticals companies are under fire. Merck was forced to withdraw its Cox-2 painkiller Vioxx when evidence emerged...

  21. January 26, 2005

    US drugs regulator attacked over Vioxx research

    The editor of a leading international medical journal joined in an attack on the US federal drugs regulator yesterday over...

  22. January 12, 2005

    Crestor gives AstraZeneca a big headache

    When AstraZeneca, the Anglo-Swedish pharmaceuticals group, received regulatory approval for its anti-cholesterol drug...

  23. January 7, 2005

    Master or servant: the US drugs regulator is put under scrutiny: Trials and tribulations of the testing process

    When David Graham, a scientist with the US Food and Drug Administration, first warned in August of the health risks of the...

  24. January 5, 2005

    Vioxx saga continues to weigh on Merck

    When Ray Gilmartin,chief executive of Merck, opened a day-long annual briefing for investors in mid-December on all aspects...

  25. January 4, 2005

    Vioxx saga continues to weigh on Merck

    When Ray Gilmartin, chief executive of Merck, in mid-December opened a day-long annual briefing for investors on all aspects...

  26. January 4, 2005

    Report alleges more Vioxx deaths

    Merck saw its shares lose as much as 3.2 per cent yesterday morning after the FT reported that further evidence of the...

  27. January 3, 2005

    Merck shares fall on Vioxx study fears

    Merck saw its shares lose as much as 3.6 per cent on Monday morning after the FT reported that further evidence of the...

  28. January 3, 2005

    Scientist vows to expose ill-effects of Vioxx

    The scientist at the centre of a dispute over the safety of the anti-inflammatory Vioxx has vowed to publish research that...

  29. January 2, 2005

    Scientist raises estimate of Vioxx ill-effects

    The scientist at the centre of a dispute over the safety of the anti-inflammatory Vioxx has vowed to publish research that...

  30. December 27, 2004

    AstraZeneca says Japan close to backing Crestor

    AstraZeneca, the Anglo-Swedish drugs group, said on Monday that the Japanese authorities were close to approving Crestor,...

  31. December 23, 2004

    Observer: Definitions

    In the high-energy world of US drug advertising, AstraZeneca's Crestor anti-cholesterol pill is a serious contender. The...

  32. December 22, 2004

    AstraZeneca heads for a grim new year

    Sir Tom McKillop has had little time for last-minute Christmas shopping in London's West End this week as he has been...

  33. December 17, 2004

    Doubts over drug safety checks

    Two-thirds of scientists working for the US medicines regulator have expressed a lack of confidence in the federal safety...

  34. November 27, 2004

    Problems in US plague City investors

    The London equity market stuttered again this week, falling on concerns about the weak dollar, the US trade deficit and how...

  35. November 26, 2004

    London falls on worries over weak dollar

    The London equity market stuttered again this week, falling as concerns about the weak dollar, the US trade deficit and how...

  36. November 26, 2004

    Safety fears plague US drug system

    US drugs regulators made two trips to Capitol Hill last week to defend themselves before Congress. They are likely to...

  37. November 25, 2004

    Safety fears plague US drug system

    US drugs regulators made two trips to Capitol Hill last week to defend themselves before Congress. They are likely to return...

  38. November 24, 2004

    FDA safety official complains of intimidation

    Controversy over conflict of interest at the US Food and Drug Administration deepened yesterday amid allegations in the...

Search for David Graham and